Malta - angličtina - Medicines Authority

stragen uk limited castle court 41, london road, reigate, surrey, rh2prj, united kingdom - gestodene, ethinylestradiol - coated tablet - gestodene 75 µg ethinylestradiol 20 µg - sex hormones and modulators of the genital system

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - ethinylestradiol, quantity: 30 microgram; drospirenone, quantity: 3 mg - tablet - excipient ingredients: maize starch; magnesium stearate; pregelatinised maize starch; lactose monohydrate; titanium dioxide; hypromellose; macrogol 400 - for use as an oral contraceptive

Malta - angličtina - Medicines Authority

heaton k.s. na pankraci 14, 140 00 praha 4, czech republic - gestodene, ethinylestradiol - film-coated tablet - gestodene 0.06 mg ethinylestradiol 0.015 mg - sex hormones and modulators of the genital system

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - ethinylestradiol, quantity: 20 microgram; drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: maize starch; lactose monohydrate; pregelatinised maize starch; magnesium stearate; titanium dioxide; hypromellose; macrogol 400 - bella is indicated for use:,? as an oral contraceptive.,? for the treatment of moderate acne vulgaris in women who seek oral contraception.,? for the treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of ethinylestradiol/drospirenone 20 microgram/3 mg tablets for pmdd was not assessed beyond 3 cycles. ethinylestradiol/drospirenone 20 microgram/3 mg tablets have not been evaluated for treatment of pms (premenstrual syndrome) (see section 5.1 pharmacodynamic properties ? clinical trials).

Malajzia - angličtina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pfizer (malaysia) sdn. bhd. - ethinylestradiol; gestoden -

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - ethinylestradiol gestodene - coated tablets - 20/75 microgram

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - ethinylestradiol gestodene - coated tablets - 30/75 microgram

Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - gestodene 50 µg (beige tablet); ethinylestradiol 30 µg (beige tablet); gestodene 70 µg (brown tablet); ethinylestradiol 40 µg (brown tablet); gestodene 100 µg (white tablet); ethinylestradiol 30 µg (white tablet) - coated tablet - ethinylestradiol 30 µg; gestodene 50 µg; gestodene 70 µg; ethinylestradiol 40 µg; gestodene 100 µg; ethinylestradiol 30 µg - gestodene and ethinylestradiol

Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bayer sa-nv - gestodene 60 µg (light yellow tablet); ethinylestradiol 15 µg (light yellow tablet); placebo (white tablet) - film-coated tablet - 60 µg - 15 µg - ethinylestradiol 15 µg; gestodene 60 µg; placebo - gestodene and ethinylestradiol

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

laboratorios leon farma, s.a. - etonogestrel; ethinylestradiol ph.eur. - vaginal delivery system - 0.120/0.015 milligram(s) - intravaginal contraceptives; vaginal ring with progestogen and estrogen